Wednesday Mar 29, 2023

Mayne Pharma’s U.S. Generic Prescription Product Portfolio Will Be Acquired by Dr. Reddy’s Laboratories

As per the press release it was announced, the generic prescription portfolio of Salisbury, Australia, based Mayne Pharma Group Limited, will be acquired by Dr. Reddy’s Laboratories, Inc. This is a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd., USA. The acquisition will add products with little competition to Dr. Reddy’s U.S. retail prescriptive pharmaceutical […]

Back to Top